- Home
- Products
Jaypirca(pirtobrutinib)
Jaypirca(pirtobrutinib)
- Medicine Name: Jaypirca Tablets
- Generic Name: Pirtobrutinib
- Dosage Form & Strength: Tablets – 50 mg, 100 mg
- Manufactured By: Eli Lilly and Company
Jaypirca (pirtobrutinib) is a non-covalent Bruton’s tyrosine kinase (BTK) inhibitor indicated for adult patients diagnosed with relapsed or refractory mantle cell lymphoma (MCL), especially those who have undergone at least two prior systemic treatments, including a BTK inhibitor.
This approval is based on response rates under the accelerated approval pathway. Continued availability depends on results from confirmatory trials validating its clinical benefit.
Recommended Dosage:
200 mg orally once daily. Tablets should be swallowed whole with water, with or without food. Do not split, chew, or crush the tablets.
Managing Toxicities:
Treatment-related adverse effects may require dose adjustment, interruption, or discontinuation. In patients with severe renal impairment, dosage modification is advised.
- Infections: Monitor closely and treat promptly if infections are suspected.
- Bleeding Risks: Monitor for signs of hemorrhage.
- Blood Cell Counts: Regular monitoring of complete blood counts is essential.
- Heart Rhythm Disorders: Watch for symptoms of atrial fibrillation or flutter.
- Secondary Cancers: Reports include skin and other carcinomas; counsel patients on sun safety.
- Fetal Risk: Can cause embryo-fetal harm. Women of reproductive potential should use effective contraception.
Common Side Effects:
Fatigue, musculoskeletal pain, diarrhea, swelling, shortness of breath, pneumonia, bruising.
Grade 3/4 Laboratory Abnormalities:
Decreased neutrophils, lymphocytes, and platelets.
Drug Interactions:
- Avoid strong CYP3A inhibitors or reduce Jaypirca dose if necessary.
- Avoid CYP3A inducers; if unavoidable, adjust Jaypirca dose accordingly.
- Monitor when co-administered with sensitive substrates of CYP2C8, CYP2C19, CYP3A, P-gp, or BCRP.
Use in Lactation:
Breastfeeding is not recommended during treatment.
To Import Jaypirca into India:
- A valid prescription from a licensed oncologist or physician
- Diagnostic test reports supporting the diagnosis
- Government-issued patient ID proof
Order Confirmation Process:
GlobalRareMeds will confirm your order upon receiving:
- A valid prescription
- Import permit (if required by Indian authorities)
Availability in India:
Jaypirca is not routinely available in Indian pharmacies. GlobalRareMeds helps patients gain access through legal, named-patient importation for personal use. Availability may vary based on international supply channels.
GlobalRareMeds sources Jaypirca (Pirtobrutinib) from trusted international suppliers across the US, Canada, Europe, and Australia. We ensure 100% compliance and transparency during procurement.
All medicines are delivered through our fulfillment center located in Ambernath, Thane District, Maharashtra. Delivery is available across India including Mumbai, Delhi, Bengaluru, Chennai, Hyderabad, and more—directly to patients, hospitals, or treating doctors.
For assistance, reach out to us at:
📧 info@globalraremeds.com
📞 +91-99675 15602
📱 WhatsApp: +91-99675 15602
What is Jaypirca used for?
Jaypirca is used to treat relapsed or refractory mantle cell lymphoma (MCL) in adult patients after at least two lines of prior treatment including a BTK inhibitor.
How is Jaypirca taken?
Jaypirca is taken orally, once daily, with or without food. Tablets must be swallowed whole with water.
Do I need a prescription to order Jaypirca?
Yes. A prescription from your oncologist or treating physician is mandatory to order Jaypirca through GlobalRareMeds.
What are the common side effects?
Common side effects include fatigue, diarrhea, swelling, muscle pain, pneumonia, shortness of breath, and bruising. Consult your doctor for full details and monitoring.
Is Jaypirca approved by the FDA?
Yes, Jaypirca received FDA approval in 2023 under the accelerated approval program.
Can Jaypirca be imported to India?
Yes. Jaypirca can be imported legally for personal use under the Named Patient Program with proper documentation.
What is the cost of Jaypirca in India?
Pricing depends on availability and international source. Contact GlobalRareMeds for the latest cost details.
Can I buy Jaypirca online in India?
Yes. GlobalRareMeds facilitates legal and compliant access to Jaypirca upon prescription and import clearance.
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
